Last reviewed · How we verify
NCT03102671
Effectiveness of the HeartHab Application on Exercise Capacity in Patients With Coronary Artery Disease
NA trial testing Use of HeartHab application followed by usual care in Coronary Artery Disease in 30 participants. Completed in 1 January 2018.
1 January 2018
Quick facts
| Lead sponsor | Hasselt University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 March 2017 |
| Primary completion | 1 January 2018 |
| Estimated completion | 1 January 2018 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Use of HeartHab application followed by usual care
- Usual care followed by the use of HeartHab application
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Hasselt University
Who can join
18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The recurrence of major cardiac events after infarction is very high, in some populations up to 20% in the first year. Optimal secondary prevention as organized in cardiac rehabilitation centers is effective in reducing both morbidity and mortality. However, many studies have shown that the participation and adherence rate in CR-programs is low in most European countries. Therefore, novel ways of delivering secondary prevention using information technology and self-monitoring are being explored. Hence, this study will investigate the effectiveness of a mobile, patient tailored, app based multidisciplinary telerehabilitation program (HeartHab app) in improving exercise capacity, lifestyle and risk factors in patients with coronary artery disease in a post-rehabilitation setting.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Evaluating the Impact of the HeartHab App on Motivation, Physical Activity, Quality of Life, and Risk Factors of Coronary Artery Disease Patients: Multidisciplinary Crossover Study.
Sankaran S, Dendale P, Coninx K. · · 2019 · cited 37× · PMID 30946021 · DOI 10.2196/10874 -
The Recent Advances of Mobile Healthcare in Cardiology Practice.
Kulbayeva S, Tazhibayeva K, Seiduanova L, Smagulova I, et al · · 2022 · cited 5× · PMID 36311150 · DOI 10.5455/aim.2022.30.236-250
Verify or expand the search:
- PubMed search for NCT03102671
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Hasselt University trials
Trials by the same sponsor.
- NCT07419100 — Sedentary Behaviour, Physical Activity Patterns, and Cardiometabolic Health · NA · not yet recruiting
- NCT07505355 — Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple Sclerosis · recruiting
- NCT07081893 — How do Patients, Relatives and Healthcare Professionals View Person-centered Rehabilitation. · not yet recruiting
- NCT06785909 — Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain. · NA · recruiting
- NCT07175792 — Accuracy of Motor Performance Perception in Multiple Sclerosis · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03102671 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hasselt University
- Last refreshed: 27 February 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03102671.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing